SMFG earnings preview: the bull case, the bear case, and the verdict
Why now
- Sumitomo Mitsui Financial Group, Inc. is scheduled to report earnings November 13, 2026 before the open. The panel argued this before the numbers came out.
The bull case
Thank you for laying out your bearish thesis. I want to directly engage with your concerns because I believe the data, when properly contextualized, actually presents a compelling buying opportunity that the market is currently mispricing. Let me build my case and challenge your core assumptions.
You've focused heavily on the $5.52B derivatives restatement and the forward earnings collapse as reasons to avoid SMFG. But here's what I think you're missing:
A. The "Crisis" is Already Priced In – Severely
Let me point out something critical: SMFG is trading at a 14x trailing P/E, which is substantially below its historical average and well below major global financial peers:
- JPMorgan Chase: ~12-14x trailing P/E (similar size, global reach)
- HSBC: ~8-10x trailing P/E (challenged by China exposure)
- Mizuho Financial: ~9-11x trailing P/E (domestic Japanese peer)
- SMFG: 14x trailing P/E ← This is the CHEAPEST on fundamentals
The restatement happened on November 9th. By now (November 10th), that shock is already absorbed into the price. The 4.7% single-day decline and 200-day MA break are capitulation moves—exactly the kind of emotional selling that creates value for contrarian investors.
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
The bear case
Thank you for that articulate bull thesis. I genuinely appreciate the intellectual rigor, but I believe you're making several critical misinterpretations of the data that obscure genuine systemic risks. Let me engage directly with your claims and expose why SMFG is far more dangerous than you've framed it.
I. Your "cheap valuation" argument ignores the real problem: earnings are collapsing
You keep returning to the 14x trailing P/E as evidence SMFG is "cheap." But this is precisely where your analysis breaks down. Let me be blunt: trailing P/E is backward-looking and irrelevant when a company is about to experience a structural earnings cliff.
A. The Forward P/E Isn't "Overly Pessimistic"—It's a Market Warning Signal
You argue the 59x forward P/E reflects temporary analyst overcorrection and that the "true" forward P/E should be 25-30x if we assume the restatement is non-cash. But here's the problem with that logic:
Market consensus estimates are compiled from dozens of institutional analysts—not retail traders. When they collectively price in a 67% earnings decline, they have reasons beyond panic.
Let me challenge your assumption directly:
- You claim: "If we simply annualize conservative cash earnings, SMFG should earn ¥0.80-0.90 per share"
- I ask: On what basis?
The fundamental data you have shows:
- TTM EPS: ¥1.73
- Forward consensus EPS: ¥0.41
- This implies: 76% earnings decline, not 67%
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
The research manager's call
Recommendation: Hold
Rationale: Both analysts made genuinely compelling arguments, and this was a high-quality debate — but neither side established a clear edge versus the S&P 500 over the next three months.
Where the Bull was strongest: The structural backdrop for SMFG is real. Net Interest Income is up +26.4% YoY, the BoJ rate-hiking cycle is a multi-year tailwind for Japanese megabanks, and the trailing P/E of ~14x with a 1.51x P/B does reflect a stock that hasn't been priced for perfection. The bull is also right that restatements are not automatically operational disasters — a non-cash derivatives accounting reclassification would leave core earnings power intact. RSI at 47.7 and improving MACD do not confirm a structural breakdown.
Where the Bear was strongest: The 59x forward P/E is not easily dismissed. Institutional consensus — compiled from dozens of analysts — is pricing in roughly a 76% EPS decline. That is not "overcorrection noise." The bear correctly identifies that the bull's recovery thesis requires three stacked, unconfirmed assumptions: (1) the restatement is non-cash, (2) no operational deterioration, and (3) NII growth continues unimpeded. None of these have been confirmed by management or regulators post-disclosure. The restatement also legitimately raises internal controls concerns. The absence of post-restatement insider buying is a fair observation. The bear's volume interpretation — that the Nov 5-6 spike pulled VWMA downward, consistent with distribution rather than accumulation — is technically sound and undercuts the bull's accumulation narrative.
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
Stress-test your own thesis on SMFG (or any US stock)
Enter a ticker, your optional thesis, and your email. Twelve AI agents will argue the bull and bear case, test your reasoning, and email your 4-page PDF report.
Unlock the full trade plan & Trader desk
Stop loss and take profit levels, position sizing, the risk team's debate and the full transcript for SMFG are in Pro ($39/mo or $379/yr, 5/day). Or upgrade to Trader ($99/mo or $949/yr, 10/day) for live position tracking vs the S&P 500, price/stop email alerts, and weekly Monday AI thesis re-checks. Pro and Trader both include an Alpaca paper-trading order ticket.
Get Pro — $39/mo →Get Trader — $99/mo →5-Report Pack — $19 one-time →Founding Lifetime Pass — $499 (20 seats) →All SMFG debates and the latest verdict →
Other recent analyses
This page was generated automatically by HedgePick's AI agents from public market data. It is general information, not personalized investment advice, and not a recommendation to buy or sell any security. AI output can be wrong or out of date. HedgePick is not a registered investment adviser or broker-dealer. Do your own research and consider your own situation before trading.